PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.\', \'State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Experimental Research, Sun Yat-sen University Cancer Center, Guangzhou, China.\', \'NHC Key Laboratory of Pulmonary Immunological Diseases, Guizhou Provincial People\'s Hospital, Guizhou University, Guizhou, China.\', \'Yangjiang Key Laboratory of Respiratory Disease, Department of Respiratory Medicine, People\'s Hospital of Yangjiang, Yangjiang, Guangdong, China.\', \'Department of Respiratory Medicine, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People\'s Hospital, Qingyuan, China.\', \'Department of Biology, Southern University of Science and Technology, Shenzhen, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1128/mBio.01372-21
?:doi
?:hasPublicationType
?:journal
  • mBio
is ?:pmid of
?:pmid
?:pmid
  • 34634929
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.106
?:rankingScore_hIndex
  • 71
is ?:relation_isRelatedTo_publication of
?:title
  • A Low-Producing Haplotype of Interleukin-6 Disrupting CTCF Binding Is Protective against Severe COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all